Inhibition of autophagy enhances the selective anti-cancer activity of tigecycline to overcome drug resistance in the treatment of chronic myeloid leukemia

Ziyuan Lu(Southern Medical University), Xiaoli Liu(Shenzhen Chronic Disease Prevention Center)
Journal of Experimental & Clinical Cancer Research
March 10, 2017
Cited by 53


Related Papers